Published in Arch Neurol on September 01, 1998
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease. Alzheimers Dement (2009) 1.49
Misregulation of gene expression in primary fibroblasts lacking poly(ADP-ribose) polymerase. Proc Natl Acad Sci U S A (2000) 1.20
Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease. J Neurol Sci (2005) 1.06
Amyloid-β42 alters apolipoprotein E solubility in brains of mice with five familial AD mutations. J Neurosci Methods (2011) 1.00
Cholesterol decreases secretion of the secreted form of amyloid precursor protein by interfering with glycosylation in the protein secretory pathway. Biochem J (2000) 0.97
Alzheimer disease and platelets: how's that relevant. Immun Ageing (2012) 0.87
Measurement of altered AβPP isoform expression in frontal cortex of patients with Alzheimer's disease by absolute quantification real-time PCR. J Alzheimers Dis (2012) 0.85
Neurochemical dementia diagnostics: assays in CSF and blood. Eur Arch Psychiatry Clin Neurosci (2008) 0.84
Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease. J Neural Transm (Vienna) (2012) 0.83
Platelets, a reliable source for peripheral Alzheimer's disease biomarkers? Acta Neuropathol Commun (2014) 0.82
Cerebrospinal fluid and blood biomarkers in Alzheimer's disease. World J Psychiatry (2011) 0.81
Platelets and Alzheimer's disease: Potential of APP as a biomarker. World J Psychiatry (2012) 0.81
Platelets in the Alzheimer's disease brain: do they play a role in cerebral amyloid angiopathy? Curr Neurovasc Res (2015) 0.81
Can platelet BACE1 levels be used as a biomarker for Alzheimer's disease? Proof-of-concept study. Platelets (2012) 0.80
Alzheimer disease-related abnormalities of amyloid beta precursor protein isoforms in the platelet: the brain's delegate in the periphery? Arch Neurol (1998) 0.78
Abnormal APP processing in platelets of patients with Alzheimer's disease: correlations with membrane fluidity and cognitive decline. Psychopharmacology (Berl) (2007) 0.78
Platelet-derived secreted amyloid-precursor protein-β as a marker for diagnosing Alzheimer's disease. Curr Neurovasc Res (2013) 0.76
Abnormalities of amyloid beta precursor protein expression in platelets of patients with Alzheimer disease: do we understand them well enough? Arch Neurol (1999) 0.76
Platelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's disease. Biogerontology (2015) 0.76
Artificial neural networks allow the use of simultaneous measurements of Alzheimer disease markers for early detection of the disease. J Transl Med (2005) 0.76
Decreased platelet APP isoform ratios in autosomal dominant Alzheimer's disease: baseline data from a DIAN cohort subset. Curr Alzheimer Res (2015) 0.75
GATE: a simulation toolkit for PET and SPECT. Phys Med Biol (2004) 7.88
Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography: theory, procedure, and normal values. J Comput Assist Tomogr (1980) 4.94
Atrial fibrillation and cognitive disorders in older people. J Am Geriatr Soc (2000) 3.59
Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry (1998) 3.07
Association of apolipoprotein E E4 with vascular dementia. JAMA (1994) 2.48
Efficacy of music therapy treatment based on cycles of sessions: a randomised controlled trial. Aging Ment Health (2010) 2.46
Epidemiological and transmissibility analysis of influenza A(H1N1)v in a southern hemisphere setting: Peru. Euro Surveill (2009) 2.35
Gadolinium-pentetic acid magnetic resonance imaging in patients with relapsing remitting multiple sclerosis. Arch Neurol (1992) 2.28
The many faces of crossed aphasia in dextrals: report of nine cases and review of the literature. Eur J Neurol (2001) 2.20
Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain (1981) 2.08
Laparoscopic surgery for inguinal hernia repair: systematic review of effectiveness and economic evaluation. Health Technol Assess (2005) 2.08
MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology (2004) 2.07
Sensory impairment and quality of life in a community elderly population. J Am Geriatr Soc (1993) 2.02
Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol (2004) 2.02
GABAergic dysfunction in mood disorders. Mol Psychiatry (2003) 2.01
Transient global amnesia as a presenting aura. Headache (2014) 1.95
Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease. FASEB J (1998) 1.86
Influence of rehabilitation on language skills in aphasic patients. A controlled study. Arch Neurol (1979) 1.79
Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease. Neurology (1999) 1.78
Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. Hum Mutat (2009) 1.77
Linear measures of atrophy in mild Alzheimer disease. AJNR Am J Neuroradiol (1996) 1.74
Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru. J Infect Dis (2000) 1.71
Object and action naming in Alzheimer's disease and frontotemporal dementia [see comment]. Neurology (1998) 1.71
Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases. Ann Rheum Dis (2009) 1.71
Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus (1999) 1.70
Unilateral neglect restricted to visual imagery. Nature (1993) 1.66
Metabolic acidosis inhibits soft tissue calcification in uremic rats. Kidney Int (2007) 1.65
Pattern of Tau forms in CSF is altered in progressive supranuclear palsy. Neurobiol Aging (2007) 1.65
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. Rheumatology (Oxford) (2002) 1.61
Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study. J Clin Psychiatry (2000) 1.60
Mini-Mental State Examination: a normative study in Italian elderly population. Eur J Neurol (1996) 1.60
Role of brain allopregnanolone in the plasticity of gamma-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. Proc Natl Acad Sci U S A (1998) 1.58
Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci (1996) 1.58
Transabdominal pre-peritoneal (TAPP) vs totally extraperitoneal (TEP) laparoscopic techniques for inguinal hernia repair. Cochrane Database Syst Rev (2005) 1.55
Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression. Am J Psychiatry (1996) 1.55
The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats. Kidney Int (2007) 1.53
Longevity and the epsilon2 allele of apolipoprotein E: the Finnish Centenarians Study. J Gerontol A Biol Sci Med Sci (2001) 1.52
Depressive symptoms of Alzheimer caregivers are mainly due to personal rather than patient factors. Int J Geriatr Psychiatry (1998) 1.51
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Neurology (2008) 1.50
Rhes: A striatal-specific Ras homolog related to Dexras1. J Neurosci Res (1999) 1.49
Frontal lobe dysfunction in essential tremor: a preliminary study. J Neurol (2001) 1.49
Good nutritional oral intake is associated with equal survival in demented and nondemented very old patients. J Am Geriatr Soc (1996) 1.48
Peroneal nerve palsy caused by thrombosis of crural veins. Neurology (2002) 1.47
Transcranial Doppler for brain death after decompressive craniectomy: persistence of cerebral blood flow with flat EEG. Intensive Care Med (2010) 1.44
A complicated case of intracranial hypotension: diagnostic and management strategies. Neurol Sci (2006) 1.44
Reactive oxygen production by cultured rat glomerular mesangial cells during phagocytosis is associated with stimulation of lipoxygenase activity. J Exp Med (1983) 1.43
Effects of sensory aids on the quality of life and mortality of elderly people: a multivariate analysis. Age Ageing (1996) 1.43
G protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain. Mol Pharmacol (1995) 1.40
Outbreak of leptospirosis in New Caledonia: diagnosis issues and burden of disease. Trop Med Int Health (2009) 1.39
Crossed aphasia with left spatial neglect and visual imperception: a case report. Neurol Sci (2003) 1.38
A case-control study on Alzheimer's disease and exposure to anesthesia. Neurol Sci (2002) 1.38
Multiple paternity increases effective size of southern Atlantic salmon populations. Mol Ecol (2000) 1.38
Enteropathogens and other factors associated with severe disease in children with acute watery diarrhea in Lima, Peru. J Infect Dis (1999) 1.38
Signet ring cell sinus histiocytosis. A previously unrecognized histologic condition mimicking metastatic adenocarcinoma in lymph nodes. Am J Clin Pathol (1989) 1.38
Recovery from aphasia and neglect after subcortical stroke: neuropsychological and cerebral perfusion study. J Neurol Neurosurg Psychiatry (1988) 1.37
Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD. Neurobiol Aging (2005) 1.37
Behavioral syndromes in Alzheimer's disease: description and correlates. Dement Geriatr Cogn Disord (1999) 1.37
Time-dependent changes in rat brain neuroactive steroid concentrations and GABAA receptor function after acute stress. Neuroendocrinology (1996) 1.36
Association between depressive symptoms and mortality in elderly people. Arch Intern Med (2001) 1.35
Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure. Health Technol Assess (2003) 1.35
Calcium/calmodulin-dependent protein kinase II is associated with NR2A/B subunits of NMDA receptor in postsynaptic densities. J Neurochem (1998) 1.33
Ethanol markedly increases "GABAergic" neurosteroids in alcohol-preferring rats. Eur J Pharmacol (1999) 1.32
Measuring depression: comparison and integration of three scales in the GENDEP study. Psychol Med (2007) 1.31
Impulsivity and bipolar disorder. Eur Neuropsychopharmacol (2006) 1.31
Contrasting results between caregiver's report and direct assessment of activities of daily living in patients affected by mild and very mild dementia: the contribution of the caregiver's personal characteristics. J Am Geriatr Soc (1999) 1.31
[Controlled study of language re-education in aphasia: comparison between treated and untreated aphasics]. Rev Neurol (Paris) (1975) 1.30
APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology (1999) 1.30
Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol (1995) 1.29
Laterality effect on emotional faces processing: ALE meta-analysis of evidence. Neurosci Lett (2009) 1.28
Understanding international differences in terminology for delirium and other types of acute brain dysfunction in critically ill patients. Intensive Care Med (2008) 1.28
Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem J (1997) 1.27
Executive dysfunction in early Alzheimer's disease. J Neurol Neurosurg Psychiatry (1996) 1.26
Comparison of five plating media for isolation of Salmonella species from human stools. J Clin Microbiol (1996) 1.25
Methadone medical maintenance (MMM): treating chronic opioid dependence in private medical practice--a summary report (1983-1998). Mt Sinai J Med (2000) 1.23
Focussed microwave radiation: a technique to minimize post mortem changes of cyclic nucleotides, dopa and choline and to preserve brain morphology. Neuropharmacology (1974) 1.23
Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence. Neurology (2008) 1.21
Effectiveness of a cognitive rehabilitation program in mild dementia (MD) and mild cognitive impairment (MCI): a case control study. Arch Gerontol Geriatr (2007) 1.20
Transabdominal pre-peritoneal (TAPP) versus totally extraperitoneal (TEP) laparoscopic techniques for inguinal hernia repair: a systematic review. Hernia (2005) 1.20
Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin. J Immunol (1987) 1.20
Neural basis of maternal communication and emotional expression processing during infant preverbal stage. Cereb Cortex (2008) 1.20
Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. J Neurol Sci (2001) 1.20
Low environmental pH is responsible for the induction of nitric-oxide synthase in macrophages. Evidence for involvement of nuclear factor-kappaB activation. J Biol Chem (1998) 1.20
Seroprevalence of and risk factors for HIV-1 infection among female commercial sex workers in South America. Sex Transm Infect (2006) 1.19